Atovaquone Suspension
Product Images NDC 68462-421

3 FDA label images from Glenmark Pharmaceuticals Inc., Usa · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Atovaquone (NDC 68462-421). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bottle Label

Bottle Label
Label for Atovaquone Oral Suspension, USP 750 mg/5 mL in a 210 mL bottle, manufactured by Glenmark Pharmaceuticals Inc., USA. The label includes storage instructions, shaking directions before use, and contact information for the manufacturer. The product is Rx only and the NDC is 68462-421-21.*
FDA Label Image
Logo
FDA Label Image

Structure

Structure
Chemical structure diagram of atovaquone, showing the arrangement of its aromatic rings, hydroxyl group, carbonyl groups, and a chlorine-substituted phenyl ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.